Germany takes the lead on regulating therapeutic allergy vaccines
This article was originally published in SRA
Executive Summary
All companies using a loophole in German law to sell allergy vaccination products, including injectables, on an unregulated named patient basis should have submitted a marketing authorisation application to the regulator by 1 December should they wish to continue to sell them there.